Aishwarya Krishnaraj

Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

Deepak L. Bhatt, Lawrence A Leiter, M. Lafreniere-Roula, 2022, Circulation.

Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease.

Lawrence A Leiter, A. Demchuk, J. Tardif, 2023, Med.